Stukan, I.; Gryzik, M.; Hoser, G.; Want, A.; Grabowska-Pyrzewicz, W.; Zdioruk, M.; Napiórkowska, M.; Cieślak, M.; Królewska-Golińska, K.; Nawrot, B.;
et al. Novel Dicarboximide BK124.1 Breaks Multidrug Resistance and Shows Anticancer Efficacy in Chronic Myeloid Leukemia Preclinical Models and Patients’ CD34+/CD38− Leukemia Stem Cells. Cancers 2022, 14, 3641.
https://doi.org/10.3390/cancers14153641
AMA Style
Stukan I, Gryzik M, Hoser G, Want A, Grabowska-Pyrzewicz W, Zdioruk M, Napiórkowska M, Cieślak M, Królewska-Golińska K, Nawrot B,
et al. Novel Dicarboximide BK124.1 Breaks Multidrug Resistance and Shows Anticancer Efficacy in Chronic Myeloid Leukemia Preclinical Models and Patients’ CD34+/CD38− Leukemia Stem Cells. Cancers. 2022; 14(15):3641.
https://doi.org/10.3390/cancers14153641
Chicago/Turabian Style
Stukan, Iga, Marek Gryzik, Grażyna Hoser, Andrew Want, Wioleta Grabowska-Pyrzewicz, Mikolaj Zdioruk, Mariola Napiórkowska, Marcin Cieślak, Karolina Królewska-Golińska, Barbara Nawrot,
and et al. 2022. "Novel Dicarboximide BK124.1 Breaks Multidrug Resistance and Shows Anticancer Efficacy in Chronic Myeloid Leukemia Preclinical Models and Patients’ CD34+/CD38− Leukemia Stem Cells" Cancers 14, no. 15: 3641.
https://doi.org/10.3390/cancers14153641
APA Style
Stukan, I., Gryzik, M., Hoser, G., Want, A., Grabowska-Pyrzewicz, W., Zdioruk, M., Napiórkowska, M., Cieślak, M., Królewska-Golińska, K., Nawrot, B., Basak, G., & Wojda, U.
(2022). Novel Dicarboximide BK124.1 Breaks Multidrug Resistance and Shows Anticancer Efficacy in Chronic Myeloid Leukemia Preclinical Models and Patients’ CD34+/CD38− Leukemia Stem Cells. Cancers, 14(15), 3641.
https://doi.org/10.3390/cancers14153641
